Multiple medical conditions require urinary diversion including radical cystectomy due to bladder cancer, refractory hematuria, radiation cystitis, or chronic pelvic pain. John Simon performed the first urinary diversion in 1851….
11.1 Introduction As minimally invasive surgery (MIS) increases in utility given the shorter hospital stays and the potentially lower surgical morbidity, surgeons will continue to strive for more efficacious techniques….
5.1 Background Open perineal radical prostatectomy was first described by Young in 1905 and remained the most common approach for surgical treatment of prostate cancer until the mid-1970s. The retropubic…
9.1 Single-port robotic surgery for kidney transplantation—rationale and conceptualization During the past decade, many centers adopted robotic-assisted kidney transplantation (RAKT) as an alternative minimally invasive procedure for kidney transplantation. A…
8.1 Introduction Prior to the da Vinci SP (Intuitive Surgical Inc.) surgical system’s introduction in 2018 and subsequent popularization in urologic robotic surgery, laparoendoscopic single-site surgery (LESS) was a technique…
10.1 Introduction Robot-assisted single-port (SP) surgery, which has been increasingly studied in the past decade, represents an opportunity to advance technology and improve patient outcomes. The da Vinci SP (Intuitive…
4.1 Introduction The advent of robotics in medicine has generated new avenues in surgical care. Robotic platforms provide surgeons with enhanced visualization and improved degrees of freedom of intraoperative movement…
6.1 Background Gettman et al. described the first cases of single site laparoscopic renal surgery in a porcine model performed via transvaginal approach. This was a natural orifice transluminal endoscopic…
3.1 Introduction Since the advent of the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, California, United States) in 2000, the robotic-assisted radical prostatectomy (RARP) has quickly risen to become the…
2.1 Introduction The da Vinci SP robot was cleared by the Food and Drug Administration (FDA) in November 2018. Due to its short life on the market, studies describing the…
